Syncom Formulations (India)20.32
-1.04 (-4.87%)

Syncom Formulations (India) Share Price

20.32-1.04 (-4.87%)
+18.00% past 1 Year

Syncom Formulations (India) Ltd. is engaged in the business of pharmaceutical formulations. The company manufactures range of products in various dosage forms and markets them in various countries. In addition

Corporate filings & documents

Announcements

Submission of copy of newspaper clippings of notice of 38th Annual General Meeting (AGM) Remote E-Voting Book Closure and other details.
2 days ago
Submission of copy of newspaper clippings of notice of 38th Annual General Meeting (AGM) Remote E-Voting Book Closure and other details.
2 days ago
PURSUANT TO REG 30 SEBI LODR WE HEREBY SUBMIT THE PRESS RELEASE ISSUED BY THE COMPANY
3 weeks ago
PURSUANT TO REG 30 SEBI LODR WE HEREBY SUBMIT THE PRESS RELEASE ISSUED BY THE COMPANY
3 weeks ago
Submission of Press Clipping Related to extract of Un-Audited Standalone and Consolidated Financial Result for the Quarter ended on 30th June 2026.
3 weeks ago
Submission of Press Clipping Related to extract of Un-Audited Standalone and Consolidated Financial Result for the Quarter ended on 30th June 2026.
3 weeks ago
Disclosure under Regulation 30(2) read with Clause 7 of Para A of Schedule /// of the SEBI (LODR) Regulation 2015: Change in directors KMP and Senior Management.
3 weeks ago
Disclosure under Regulation 30(2) read with Clause 7 of Para A of Schedule /// of the SEBI (LODR) Regulation 2015: Change in directors KMP and Senior Management.
3 weeks ago
Corporate Announcement/Information pursuant to Regulation 44 of the SEBI (LODR) Regulation 2015 regarding providing Remote E-Voting facilities for the 38th Annual General Meeting to be held on 30th September 2026.
3 weeks ago
Corporate Announcement/Information pursuant to Regulation 44 of the SEBI (LODR) Regulation 2015 regarding providing Remote E-Voting facilities for the 38th Annual General Meeting to be held on 30th September 2026.
3 weeks ago
Appointment of Cost Auditor and Internal Auditor for the FY 2026-27.
3 weeks ago
Appointment of Cost Auditor and Internal Auditor for the FY 2026-27.
3 weeks ago
Pursuant to Regulation 33(3) of SEBI (LODR) Regulations 2015 we are pleased to submit the Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report thereon for the Quarter ended 30th June 2026 in PDF Format which were also approved and recommended by the Audit Committee and further approved by the Board of Directors at their meeting held on Tuesday 11th August 2026.
3 weeks ago
Pursuant to Regulation 33(3) of SEBI (LODR) Regulations 2015 we are pleased to submit the Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report thereon for the Quarter ended 30th June 2026 in PDF Format which were also approved and recommended by the Audit Committee and further approved by the Board of Directors at their meeting held on Tuesday 11th August 2026.
3 weeks ago
We are pleased to inform you that pursuant to the provision of Regulation 42 of SEBI (LODR) Regulations 2015 and Section 91 of the Companies Act 2013 the "Record Date" has been fixed as Wednesday 23rd September 2026 for the purpose of determining the entitlement of members for payment of dividend at the rate of 10% each for the financial year 2025-26 if any subject to approval by the member at their ensuing 38th Annual General Meeting of the company.
3 weeks ago
We are pleased to inform you that pursuant to the provision of Regulation 42 of SEBI (LODR) Regulations 2015 and Section 91 of the Companies Act 2013 the "Record Date" has been fixed as Wednesday 23rd September 2026 for the purpose of determining the entitlement of members for payment of dividend at the rate of 10% each for the financial year 2025-26 if any subject to approval by the member at their ensuing 38th Annual General Meeting of the company.
3 weeks ago
Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on Tuesday 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations 2015.
3 weeks ago
Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on Tuesday 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations 2015.
3 weeks ago
Revised Intimation for resignation of Mr. Vijay Shankarlal Bankda Managing Director Under Regulation 30 of SEBI (LODR) Regulations 2015.
3 weeks ago
Revised Intimation for resignation of Mr. Vijay Shankarlal Bankda Managing Director Under Regulation 30 of SEBI (LODR) Regulations 2015.
3 weeks ago
Intimation for Resignation of Mr. Vijay Shankarlal Bankda Managing Director under Regulation 30 of SEBI (LODR) Regulations 2015
3 weeks ago
Intimation for Resignation of Mr. Vijay Shankarlal Bankda Managing Director under Regulation 30 of SEBI (LODR) Regulations 2015
3 weeks ago
Intimation for Resignation of Mr. Rahul Vijay Bankda Chief Financial Officer (CFO) under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015
3 weeks ago
Intimation for Resignation of Mr. Rahul Vijay Bankda Chief Financial Officer (CFO) under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015
3 weeks ago
Intimation for Resignation of Mr. Kedarmal Shankarlal Bankda Whole-Time Director under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015
3 weeks ago
Intimation for Resignation of Mr. Kedarmal Shankarlal Bankda Whole-Time Director under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015
3 weeks ago
Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulation 2015 we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the company is scheduled to be held on Tuesday the 11th day of August 2026 at 4:00 P.M. at the Corporate office of the company to consider and recommend the Final Dividend on equity share of the Company for the Financial Year ended 31st March 2026 if any;
4 weeks ago
Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulation 2015 we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the company is scheduled to be held on Tuesday the 11th day of August 2026 at 4:00 P.M. at the Corporate office of the company to consider and recommend the Final Dividend on equity share of the Company for the Financial Year ended 31st March 2026 if any;
4 weeks ago
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday the 11th day of August 2026 at 4:00 P.M. (IST) at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018
4 weeks ago
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday the 11th day of August 2026 at 4:00 P.M. (IST) at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018
4 weeks ago
Certificate for compliance of regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 30th June 2026
1 month ago
Certificate for compliance of regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 30th June 2026
1 month ago
Notice for Trading window Closure for the financials of the quarter ended 30.06.2026
2 months ago
Notice for Trading window Closure for the financials of the quarter ended 30.06.2026
2 months ago
Submission of Press Clipping related to extract of Audited Financial Results for the year ended 31.03.2026
3 months ago
Submission of Press Clipping related to extract of Audited Financial Results for the year ended 31.03.2026
3 months ago
Pursuant to regulation 33(3)(d) of SEBI LODR Regulations 2015 we are pleased to submit the financials for the year ended on 31st March 2026
3 months ago
Pursuant to regulation 33(3)(d) of SEBI LODR Regulations 2015 we are pleased to submit the financials for the year ended on 31st March 2026
3 months ago
Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations 2015 we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors Report thereon by Statutory Auditors Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March 2026 in PDF Format which were approved by the Audit Committee and Board of Directors at their meeting held on Friday 22nd May 2026.
3 months ago
In terms of REG 24A of Listing Regulations as amended read with master circular we hereby submit the Annual Secretarial Compliance Report for the year ended 31st March 2026
3 months ago
In terms of REG 24A of Listing Regulations as amended read with master circular we hereby submit the Annual Secretarial Compliance Report for the year ended 31st March 2026
3 months ago
In terms of REG 24A of Listing Regulations as amended read with master circular we hereby submit the Annual Secretarial Compliance Report for the year ended 31st March 2026
3 months ago
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 1/2026-27 Meeting of the Board of Directors of the Company is scheduled to be held on Friday the 22nd day of May 2026 at 3:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018
3 months ago
Pursuant to Reg 30 we want to inform that the company has purchased a property
4 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Syncom Formulations India Ltd-</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24239MH1988PLC047759</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: VAISHALI AGRAWAL <br/> Designation: COMAPNY SECRETARY <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: RAHUL VIJAY BANKDA <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 07/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago
Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) Regulation 2018 for the quarter ended 31st March 2026
4 months ago
Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) Regulation 2018 for the quarter ended 31st March 2026
4 months ago
Pursuant to the regulation 31(4) of SEBI (SAST) Regulations 2011 we would like to inform that the following promoters along with their persons acting in concert have provided a copy of the yearly disclosure for the financial year ended on 31st March 2026.
5 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Syncom Formulations India Ltd-</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24239MH1988PLC047759</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. YES</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: VAISHALI AGRAWAL <br/> Designation: COMPANY SECRETARY <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Rahul Bankda <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 03/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Syncom Formulations India Ltd-</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24239MH1988PLC047759</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. YES</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: VAISHALI AGRAWAL <br/> Designation: COMPANY SECRETARY <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Rahul Bankda <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 03/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago

Concalls & investor presentations

Empty box

No presentations found

Corporate Actions

Date
Type
Details
2026-09-23
Dividend
0.1

Company details

Registered office

7 Niraj Industrial Estate Off Mahakali Caves Road Andheri (E) Mumbai Maharashtra PIN: 400093 Tel No: 022 30887744 / 54 Fax No: 022 30887755 Email: [email protected] Internet: www.sfil.in

Registrars

Plot No. 60, Electronic Complex, Pardeshipura, Indore (M.P.)-452010 Plot No 60 Electronic Complex Pardeshipura PIN: Tel No: NULL Fax No: NULL Email: NULL

Management

Vaishali Agrawal, Company Secretary & Compliance Officer

Ruchi Jindal, Non Executive Independent Woman Director

Ritesh Kumar Lunkad, Non Executive Independent Director

Ankit Jain, Non Executive Independent Director

Ankit Kedarmal Bankda, Executive Chairman & Whole-time Director

Details

BSE 524470

NSE SYNCOMF

ISIN INE312C01025

Syncom Formulations (India) Ltd Share Price Today

The Syncom Formulations (India) Ltd share price today is ₹22.21. During the trading session, the Syncom Formulations (India) Ltd share price opened at ₹21.43 and recorded an intraday high of ₹22.25 and a low of ₹21.18. Last closing price was ₹21.39. Over the past 52 weeks, the Syncom Formulations (India) Ltd share price has ranged between ₹10.21 and ₹22.25. The current Syncom Formulations (India) Ltd stock price reflects real-time market activity based on executed trades on the exchange.